Search details
1.
Multicenter Evaluation of Circulating Cell-Free DNA Extraction and Downstream Analyses for the Development of Standardized (Pre)analytical Work Flows.
Clin Chem
; 66(1): 149-160, 2020 01 01.
Article
in English
| MEDLINE | ID: mdl-31628139
2.
Multicenter Evaluation of Circulating Plasma MicroRNA Extraction Technologies for the Development of Clinically Feasible Reverse Transcription Quantitative PCR and Next-Generation Sequencing Analytical Work Flows.
Clin Chem
; 65(9): 1132-1140, 2019 09.
Article
in English
| MEDLINE | ID: mdl-31235535
3.
ITIH5 induces a shift in TGF-ß superfamily signaling involving Endoglin and reduces risk for breast cancer metastasis and tumor death.
Mol Carcinog
; 57(2): 167-181, 2018 02.
Article
in English
| MEDLINE | ID: mdl-28940371
4.
ITIH5 mediates epigenetic reprogramming of breast cancer cells.
Mol Cancer
; 16(1): 44, 2017 02 23.
Article
in English
| MEDLINE | ID: mdl-28231808
5.
Gene expression analysis combined with functional genomics approach identifies ITIH5 as tumor suppressor gene in cervical carcinogenesis.
Mol Carcinog
; 56(6): 1578-1589, 2017 06.
Article
in English
| MEDLINE | ID: mdl-28059468
6.
Promoter hypermethylation of the tumor-suppressor genes ITIH5, DKK3, and RASSF1A as novel biomarkers for blood-based breast cancer screening.
Breast Cancer Res
; 15(1): R4, 2013 Jan 15.
Article
in English
| MEDLINE | ID: mdl-23320751
7.
Integrating circulating miRNA analysis in the clinical management of lung cancer: Present or future?
Mol Aspects Med
; 72: 100844, 2020 04.
Article
in English
| MEDLINE | ID: mdl-31959359
8.
Multicenter Evaluation of Independent High-Throughput and RT-qPCR Technologies for the Development of Analytical Workflows for Circulating miRNA Analysis.
Cancers (Basel)
; 12(5)2020 May 05.
Article
in English
| MEDLINE | ID: mdl-32380788
9.
Correction: SNiPER: a novel hypermethylation biomarker panel for liquid biopsy based early breast cancer detection.
Oncotarget
; 11(30): 2958, 2020 Jul 28.
Article
in English
| MEDLINE | ID: mdl-32774775
10.
Technical Evaluation of Commercial Mutation Analysis Platforms and Reference Materials for Liquid Biopsy Profiling.
Cancers (Basel)
; 12(6)2020 Jun 16.
Article
in English
| MEDLINE | ID: mdl-32560092
11.
Circulating Tumor Cell PD-L1 Expression as Biomarker for Therapeutic Efficacy of Immune Checkpoint Inhibition in NSCLC.
Cells
; 8(8)2019 08 01.
Article
in English
| MEDLINE | ID: mdl-31374957
12.
SNiPER: a novel hypermethylation biomarker panel for liquid biopsy based early breast cancer detection.
Oncotarget
; 10(60): 6494-6508, 2019 Nov 05.
Article
in English
| MEDLINE | ID: mdl-31741713
13.
Epigenetic loss of putative tumor suppressor SFRP3 correlates with poor prognosis of lung adenocarcinoma patients.
Epigenetics
; 13(3): 214-227, 2018.
Article
in English
| MEDLINE | ID: mdl-27623992
14.
Liquid biopsy in colon cancer: comparison of different circulating DNA extraction systems following absolute quantification of KRAS mutations using Intplex allele-specific PCR.
Oncotarget
; 8(49): 86253-86263, 2017 Oct 17.
Article
in English
| MEDLINE | ID: mdl-29156792
15.
Abundant NDRG2 Expression Is Associated with Aggressiveness and Unfavorable Patients' Outcome in Basal-Like Breast Cancer.
PLoS One
; 11(7): e0159073, 2016.
Article
in English
| MEDLINE | ID: mdl-27400234
16.
Low expression of ITIH5 in adenocarcinoma of the lung is associated with unfavorable patients' outcome.
Epigenetics
; 10(10): 903-12, 2015.
Article
in English
| MEDLINE | ID: mdl-26252352
17.
Epigenetic inactivation of the novel candidate tumor suppressor gene ITIH5 in colon cancer predicts unfavorable overall survival in the CpG island methylator phenotype.
Epigenetics
; 9(9): 1290-301, 2014 Sep.
Article
in English
| MEDLINE | ID: mdl-25093535
Results
1 -
17
de 17
1
Next >
>>